Clinical Trial Update: Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing tegoprazan and pantoprazole for acid suppression and symptom management in gastroesophageal reflux disease, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)
• Tegoprazan (tegoprazan)

Snippet

Sponsor: Carnot Laboratories | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: RECRUITING